Oral citrulline as arginine precursor may be beneficial in sickle cell disease: early phase two results (Q28363043)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oral citrulline as arginine precursor may be beneficial in sickle cell disease: early phase two results |
scientific article |
Statements
Oral citrulline as arginine precursor may be beneficial in sickle cell disease: early phase two results (English)
0 references
October 2001
0 references
93
0 references
10
0 references
363-71
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference